Skip to main content
Addgene

pcDNA3.1 SIRT6_H133Y Citations (4)

Originally described in: SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin.
Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, Chang HY, Bohr VA, Ried T, Gozani O, Chua KF Nature. 2008 Mar 27;452(7186):492-6. doi: 10.1038/nature06736. Epub 2008 Mar 12.
PubMed Journal

Articles Citing pcDNA3.1 SIRT6_H133Y

Articles
SIRT6 protects against lipopolysaccharide (LPS)-induced apoptosis in human dental pulp cells by deacetylation of Ku70. Chen W, Chen X, Sun Y. Biochem Biophys Res Commun. 2016 Nov 1. pii: S0006-291X(16)31832-0. doi: 10.1016/j.bbrc.2016.10.137. PubMed
Deacetylation of Ku70 by SIRT6 attenuates Bax-mediated apoptosis in hepatocellular carcinoma. Tao NN, Ren JH, Tang H, Ran LK, Zhou HZ, Liu B, Huang AL, Chen J. Biochem Biophys Res Commun. 2017 Apr 15;485(4):713-719. doi: 10.1016/j.bbrc.2017.02.111. Epub 2017 Feb 24. PubMed
Aberrant SIRT6 expression contributes to melanoma growth: Role of the autophagy paradox and IGF-AKT signaling. Wang L, Guo W, Ma J, Dai W, Liu L, Guo S, Chen J, Wang H, Yang Y, Yi X, Wang G, Gao T, Zhu G, Li C. Autophagy. 2018;14(3):518-533. doi: 10.1080/15548627.2017.1384886. Epub 2017 Dec 31. PubMed
Protective effects of SIRT6 against lipopolysaccharide (LPS) are mediated by deacetylation of Ku70. Zhang L, Bai L, Ren Q, Sun G, Si Y. Mol Immunol. 2018 Sep;101:312-318. doi: 10.1016/j.molimm.2018.07.009. Epub 2018 Jul 20. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.